Cupid Limited Strengthens IVD Test Kits Business with Certification Pipeline, Capacity Expansion, and Global Market Expansion

Mumbai (Maharashtra) [India], August 9: Cupid Limited (BSE – 530843, NSE – CUPID) is rapidly scaling its In-Vitro Diagnostic (IVD) test kits business, driven by strong domestic demand, a growing international footprint and a clear expansion strategy.

Key Highlights:

• Diverse Product Portfolio: 15 IVD rapid test kits currently in production, including HIV, Syphilis, Pregnancy, and Hepatitis B; 3 new kits under development.

• Regulatory Certifications in Progress:

o CE Certification for 4 key products expected soon in 2025.

o WHO…